
Ilia I. Ouspenski
Examiner (ID: 3638, Phone: (571)272-2920 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1644 |
| Total Applications | 1610 |
| Issued Applications | 1040 |
| Pending Applications | 153 |
| Abandoned Applications | 440 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11421323
[patent_doc_number] => 20170029467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'METHOD OF PRODUCING BIVALIRUDIN'
[patent_app_type] => utility
[patent_app_number] => 15/168745
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11198
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15168745
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/168745 | METHOD OF PRODUCING BIVALIRUDIN | May 30, 2016 | Abandoned |
Array
(
[id] => 11113625
[patent_doc_number] => 20160310597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'Caspofungin Acetate Formulations'
[patent_app_type] => utility
[patent_app_number] => 15/165389
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8440
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15165389
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/165389 | Caspofungin Acetate Formulations | May 25, 2016 | Abandoned |
Array
(
[id] => 11289153
[patent_doc_number] => 20160339084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-24
[patent_title] => 'Long-Acting Formulations of Insulin'
[patent_app_type] => utility
[patent_app_number] => 15/162563
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 30334
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15162563
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/162563 | Long-Acting Formulations of Insulin | May 22, 2016 | Abandoned |
Array
(
[id] => 11542627
[patent_doc_number] => 20170096451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'INHIBITION OF GLIADIN PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/160259
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16443
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15160259
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/160259 | INHIBITION OF GLIADIN PEPTIDES | May 19, 2016 | Abandoned |
Array
(
[id] => 12702130
[patent_doc_number] => 20180125876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages
[patent_app_type] => utility
[patent_app_number] => 15/574868
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574868
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574868 | Methods and Pharmaceutical Composition for Modulation Polarization and Activation of Macrophages | May 19, 2016 | Abandoned |
Array
(
[id] => 17830097
[patent_doc_number] => 20220267401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => METHOD FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTEIN HORMONES
[patent_app_type] => utility
[patent_app_number] => 16/086284
[patent_app_country] => US
[patent_app_date] => 2016-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086284
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086284 | METHOD FOR PRODUCING AND PURIFYING HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, HYBRID OR NON-HYBRID RECOMBINANT GLYCOPROTEIN HORMONES, EXPRESSION VECTORS AND USES OF THE RECOMBINANT GLYCOPROTEIN HORMONES | May 9, 2016 | Abandoned |
Array
(
[id] => 11656094
[patent_doc_number] => 09669076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Albumin-free factor VIII formulations'
[patent_app_type] => utility
[patent_app_number] => 15/146835
[patent_app_country] => US
[patent_app_date] => 2016-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7615
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15146835
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/146835 | Albumin-free factor VIII formulations | May 3, 2016 | Issued |
Array
(
[id] => 12656929
[patent_doc_number] => 20180110809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => Bioassimilable protein-melanin complex, preparation and uses
[patent_app_type] => utility
[patent_app_number] => 15/569863
[patent_app_country] => US
[patent_app_date] => 2016-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569863 | Bioassimilable protein-melanin complex, preparation and uses | Apr 28, 2016 | Issued |
Array
(
[id] => 12584880
[patent_doc_number] => 20180086789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => PHARMACEUTICAL COMPOUND
[patent_app_type] => utility
[patent_app_number] => 15/569541
[patent_app_country] => US
[patent_app_date] => 2016-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569541
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569541 | PHARMACEUTICAL COMPOUND | Apr 27, 2016 | Abandoned |
| 15/135625 | Methods for Measuring Consumption of Amino Acid N-Carboxyanhydrides during Manufacture of Glatiramer Acetate | Apr 21, 2016 | |
Array
(
[id] => 11046292
[patent_doc_number] => 20160243251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-25
[patent_title] => 'ARTIFICIAL TRANSCRIPTION FACTORS COMPRISING A SLIDING DOMAIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/099371
[patent_app_country] => US
[patent_app_date] => 2016-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23678
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15099371
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/099371 | Artificial transcription factors comprising a sliding domain and uses thereof | Apr 13, 2016 | Issued |
Array
(
[id] => 11099690
[patent_doc_number] => 20160296660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROMOTING HEMOSTASIS AND OTHER PHYSIOLOGICAL ACTIVITIES'
[patent_app_type] => utility
[patent_app_number] => 15/091435
[patent_app_country] => US
[patent_app_date] => 2016-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25193
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15091435
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/091435 | Compositions and methods for promoting hemostasis and other physiological activities | Apr 4, 2016 | Issued |
Array
(
[id] => 12657091
[patent_doc_number] => 20180110863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-26
[patent_title] => GLUCOSE-RESPONSIVE INSULIN CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 15/564805
[patent_app_country] => US
[patent_app_date] => 2016-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15564805
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/564805 | GLUCOSE-RESPONSIVE INSULIN CONJUGATES | Apr 3, 2016 | Abandoned |
Array
(
[id] => 13311373
[patent_doc_number] => 20180207223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/558013
[patent_app_country] => US
[patent_app_date] => 2016-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558013
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558013 | PCSK9 INHIBITORY POLYPOLYPEPTIDES AND METHODS OF USE | Mar 18, 2016 | Abandoned |
Array
(
[id] => 12183307
[patent_doc_number] => 20180042243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'REAGENTS AND METHODS FOR INHIBITING OR DISRUPTING BIOFILM'
[patent_app_type] => utility
[patent_app_number] => 15/557812
[patent_app_country] => US
[patent_app_date] => 2016-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 8632
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557812
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557812 | Reagents and methods for inhibiting or disrupting biofilm | Mar 10, 2016 | Issued |
Array
(
[id] => 12204857
[patent_doc_number] => 20180050082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'SERPINS FOR THE TREATMENT OF NEUROINFLAMMATORY DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/556608
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17171
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15556608
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/556608 | SERPINS FOR THE TREATMENT OF NEUROINFLAMMATORY DISEASES | Mar 8, 2016 | Abandoned |
Array
(
[id] => 11120633
[patent_doc_number] => 20160317607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'Purified Amphiphilic Peptide Compositions and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/065758
[patent_app_country] => US
[patent_app_date] => 2016-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11496
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15065758
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/065758 | Purified Amphiphilic Peptide Compositions and Uses Thereof | Mar 8, 2016 | Abandoned |
Array
(
[id] => 10978435
[patent_doc_number] => 20160175378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'NEW KETOGENIC DIET AND ITS USE IN TREATING THE CRITICALLY ILL'
[patent_app_type] => utility
[patent_app_number] => 15/056473
[patent_app_country] => US
[patent_app_date] => 2016-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5714
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15056473
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/056473 | NEW KETOGENIC DIET AND ITS USE IN TREATING THE CRITICALLY ILL | Feb 28, 2016 | Abandoned |
Array
(
[id] => 12831808
[patent_doc_number] => 20180169108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => Drug Combinations For the Treatment of HIV
[patent_app_type] => utility
[patent_app_number] => 15/552452
[patent_app_country] => US
[patent_app_date] => 2016-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18328
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552452
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/552452 | Drug Combinations For the Treatment of HIV | Feb 18, 2016 | Abandoned |
Array
(
[id] => 13968307
[patent_doc_number] => 10213487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Nasal powder formulation for treatment of hypoglycemia
[patent_app_type] => utility
[patent_app_number] => 15/545332
[patent_app_country] => US
[patent_app_date] => 2016-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11879
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545332
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545332 | Nasal powder formulation for treatment of hypoglycemia | Feb 15, 2016 | Issued |